Roberta Mazzieri

6.8k total citations · 2 hit papers
60 papers, 5.2k citations indexed

About

Roberta Mazzieri is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Roberta Mazzieri has authored 60 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 23 papers in Immunology and 20 papers in Oncology. Recurrent topics in Roberta Mazzieri's work include Protease and Inhibitor Mechanisms (15 papers), Immune cells in cancer (9 papers) and Immunotherapy and Immune Responses (8 papers). Roberta Mazzieri is often cited by papers focused on Protease and Inhibitor Mechanisms (15 papers), Immune cells in cancer (9 papers) and Immunotherapy and Immune Responses (8 papers). Roberta Mazzieri collaborates with scholars based in Australia, Italy and United States. Roberta Mazzieri's co-authors include Daniel B. Rifkin, Luigi Naldini, John S. Munger, Paolo Mignatti, Pierre‐Emmanuel Gleizes, Davide Moi, Erika Zonari, Ferdinando Pucci, Michele De Palma and John G. Harpel and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Roberta Mazzieri

59 papers receiving 5.1k citations

Hit Papers

Targeting the ANG2/TIE2 A... 2011 2026 2016 2021 2011 2014 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Roberta Mazzieri 2.7k 1.3k 1.3k 1.3k 792 60 5.2k
Minhong Yan 3.9k 1.4× 1.5k 1.1× 1.4k 1.1× 3.0k 2.3× 363 0.5× 51 7.6k
Deborah L. French 2.4k 0.9× 1.0k 0.8× 741 0.6× 1.0k 0.8× 539 0.7× 134 5.3k
Yoshito Ueyama 3.2k 1.2× 1.0k 0.8× 2.6k 1.9× 1.3k 1.0× 684 0.9× 198 6.5k
Katherine N. Weilbaecher 2.5k 0.9× 817 0.6× 3.2k 2.4× 1.3k 1.0× 331 0.4× 124 6.1k
Robert Friesel 4.5k 1.7× 907 0.7× 844 0.6× 531 0.4× 707 0.9× 85 6.2k
Cheryl D. Helgason 3.1k 1.2× 742 0.6× 882 0.7× 1.8k 1.4× 297 0.4× 71 5.2k
Boye Schnack Nielsen 2.7k 1.0× 3.1k 2.3× 1.5k 1.2× 705 0.5× 312 0.4× 119 5.5k
Kenn Holmbeck 2.0k 0.7× 2.6k 1.9× 1.8k 1.4× 555 0.4× 427 0.5× 63 5.2k
Naomi Fukai 4.1k 1.5× 2.0k 1.5× 1.1k 0.9× 391 0.3× 762 1.0× 41 6.8k
Thomas Maciag 5.3k 2.0× 1.0k 0.8× 741 0.6× 824 0.6× 699 0.9× 63 7.3k

Countries citing papers authored by Roberta Mazzieri

Since Specialization
Citations

This map shows the geographic impact of Roberta Mazzieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Mazzieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Mazzieri more than expected).

Fields of papers citing papers by Roberta Mazzieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Mazzieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Mazzieri. The network helps show where Roberta Mazzieri may publish in the future.

Co-authorship network of co-authors of Roberta Mazzieri

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Mazzieri. A scholar is included among the top collaborators of Roberta Mazzieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Mazzieri. Roberta Mazzieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dolcetti, Riccardo, et al.. (2025). Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?. Journal of Experimental & Clinical Cancer Research. 44(1). 98–98. 2 indexed citations
2.
Jhaveri, Niyati, Aditya Pratapa, Riccardo Dolcetti, et al.. (2024). Abstract 3763: Comparative spatial analyses of the tumor immune landscape in different mouse models of glioblastoma. Cancer Research. 84(6_Supplement). 3763–3763. 1 indexed citations
3.
Raninga, Prahlad V., Bijun Zeng, Davide Moi, et al.. (2024). CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers. Oncogene. 44(13). 893–908. 2 indexed citations
4.
Chen, Shuxiong, et al.. (2023). Targeting Tumor Heterogeneity with Neoantigen-Based Cancer Vaccines. Cancer Research. 84(3). 353–363. 27 indexed citations
5.
Waryah, Charlene, Roberta Mazzieri, Riccardo Dolcetti, et al.. (2023). Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs. Cancers. 15(12). 3152–3152. 3 indexed citations
6.
Zeng, Bijun, Davide Moi, Ian H. Frazer, et al.. (2023). Skin-Grafting and Dendritic Cell “Boosted” Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines. Cells. 12(16). 2094–2094. 1 indexed citations
7.
Janjua, Taskeen Iqbal, Aria Ahmed-Cox, Anand Kumar Meka, et al.. (2021). Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma. Nanoscale. 13(40). 16909–16922. 52 indexed citations
8.
Zeng, Bijun, Anton P. J. Middelberg, Kelli P. A. MacDonald, et al.. (2018). Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy. Journal of Clinical Investigation. 128(5). 1971–1984. 74 indexed citations
9.
Mazzieri, Roberta, et al.. (2018). Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance. Frontiers in Oncology. 8. 322–322. 139 indexed citations
10.
Tuong, Zewen Kelvin, T Kobayashi, Megan S. F. Soon, et al.. (2017). B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity. OncoImmunology. 7(2). e1393599–e1393599. 15 indexed citations
11.
Song, Wenzhe, Roberta Mazzieri, Tao Yang, & Glenda C. Gobé. (2017). Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial–Mesenchymal Transition. Frontiers in Immunology. 8. 1106–1106. 81 indexed citations
12.
Ferrari, Giulio, Chiara Giacomini, Fabio Bignami, et al.. (2016). Angiopoietin 2 expression in the cornea and its control of corneal neovascularisation. British Journal of Ophthalmology. 100(7). 1005–1010. 10 indexed citations
13.
Mazzieri, Roberta, Giovanni Pietrogrande, Alessandro Gandelli, et al.. (2015). Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1. Cancer Research. 75(22). 4895–4909. 10 indexed citations
14.
Ronca, Roberto, Arianna Giacomini, Emanuela Di Salle, et al.. (2015). Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy. Cancer Cell. 28(3). 399–399. 6 indexed citations
15.
Mazzieri, Roberta, Ferdinando Pucci, Davide Moi, et al.. (2011). Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells. Cancer Cell. 19(4). 512–526. 489 indexed citations breakdown →
16.
Palma, Michele De, Roberta Mazzieri, Letterio S. Politi, et al.. (2008). Tumor-Targeted Interferon-α Delivery by Tie2-Expressing Monocytes Inhibits Tumor Growth and Metastasis. Cancer Cell. 14(4). 299–311. 235 indexed citations
17.
Mazzieri, Roberta, Vladimir Jurukovski, Hiroto Obata, et al.. (2005). Expression of truncated latent TGF-β-binding protein modulates TGF-β signaling. Journal of Cell Science. 118(10). 2177–2187. 33 indexed citations
18.
Mazzieri, Roberta, et al.. (2005). An Uncleavable uPAR Mutant Allows Dissection of Signaling Pathways in uPA-dependent Cell Migration. Molecular Biology of the Cell. 17(1). 367–378. 60 indexed citations
19.
Isogai, Zenzo, Robert N. Ono, Shin Ushiro, et al.. (2003). Latent Transforming Growth Factor β-binding Protein 1 Interacts with Fibrillin and Is a Microfibril-associated Protein. Journal of Biological Chemistry. 278(4). 2750–2757. 426 indexed citations
20.
Munger, John S., John G. Harpel, Pierre‐Emmanuel Gleizes, et al.. (1997). Latent transforming growth factor-β: Structural features and mechanisms of activation. Kidney International. 51(5). 1376–1382. 438 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026